CTRI/2023/06/054356进行中（未招募）Unknown
Effectiveness of ceftazidime avibactam for the treatment of bacteremia due to MDR gram negative Infection - NI
Medanta Institute of Education and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Adult patients, Bacteremic patients with Documented MDR GNB infection, Received ceftazidimeavibactam for atleast 48 hours as per clinician’s discretion
排除标准
- •Documented Acinetobacter infection, Pure MBL isolated (if available)
研究者
相似试验
尚未招募
Unknown
rosepsis and Intra abdominal SepsisCTRI/2024/05/066803Pfizer PHARMACEUTICALS
尚未招募
Unknown
Study to evaluate clinical effects of Polymyxins and Ceftazidime-Avibactum in critical patients and evaluate which group has better outcomes (CoP CAcRE)CTRI/2023/10/058761Research institution
尚未招募
4 期
Impact of Rapid Diagnostics using a FilmArray Test and Early Targeted Treatment with Ceftazidime-Avibactam for Management of Severe Infections: A Comparative Study Against Standard CareCTRI/2024/04/066197ADVANCE ID
尚未招募
1 期
Comparing the efficacy of two antibiotic groups for gram negative sepsis in intensive care unitCTRI/2024/04/065863Trishita Saha
尚未招募
不适用
Precise Treatment of Ceftazidime-Avibactam in Patients With CRO Infections Under the Guidance of TDM and PPK ModelECMOCarbapenem-Resistant Enterobacteriaceae InfectionNCT06210542Sichuan Provincial People's Hospital50